María Figueres Oñate
Postdoctoral researcher at the Instituto de Investigaciones Raras Health Institute Carlos III
[The two papers published by the Braun and Siletti teams] come from a pioneering research institute of great importance in the field of omics, Karolinska, and are associated with one of the leading and reference groups in the field, led by Sten Linnarsson. Therefore, I believe that the articles present a good scientific rigour, since many of the new technologies that have been developed in the field of omics come from these authors.
On the other hand, I think it is a great advance to be able to obtain transcriptomic information, which reflects which genes each cell is expressing, from the human brain, both in its adult state and, above all, in development, as these articles show. When it comes to extrapolating to humans, most studies are based on experimental models to try to understand or replicate what might happen. Therefore, being able to create these atlases of cell types in different brain areas at different times seems to me to be a great tool to bring us closer to a better understanding of the human brain and to more accurately match their homology with the experimental models we work with.
In addition, much of the single-cell transcriptomic sequencing work lacks spatial information in the tissue itself, making it difficult to relate the massive sequencing data to the location and dispersion of cells in situ. The work of Braun et al. makes this effort and not only collects gene expression data, but also employs techniques to identify in which specific areas of the developing brain different cell types are located.
Undoubtedly, there is still some way to go in the field of human genetics, especially in collecting data from diverse populations to avoid bias. Overall, however, this material provides a valuable starting point for understanding the heterogeneity and variability present in the human brain.